title: Candidemia in patients with ventricular assist devices.
abstract: During the period 1998-2004, candidemia developed in 7 of 117 ventricular assist device recipients at our hospital, and the associated mortality rate was 71%. Five cases of candidemia were due to Candida parapsilosis, and 2 were due to Candida albicans. Three of the 7 patients with ventricular assist device-associated Candida bloodstream infections were cured, and the device was retained in 2 of the 3 patients.
authors.affiliation: Department of Infectious Diseases, Washington Hospital Center, Washington, DC 20010, USA. Shmuel.Shoham@medstar.net
authors.forename: Shmuel
authors.initials: S
authors.lastname: Shoham
authors.forename: Rebecca
authors.initials: R
authors.lastname: Shaffer
authors.forename: Leslie
authors.initials: L
authors.lastname: Sweet
authors.forename: Richard
authors.initials: R
authors.lastname: Cooke
authors.forename: Nancy
authors.initials: N
authors.lastname: Donegan
authors.forename: Steven
authors.initials: S
authors.lastname: Boyce
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D016022:Case-Control Studies; D005260:Female; D016469:Fungemia / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000935:Antifungal Agents